{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:46:18Z","timestamp":1785876378902,"version":"3.56.0"},"reference-count":26,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"8","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>\n                      Isocitrate dehydrogenase 1 and 2 (\n                      <jats:italic toggle=\"yes\">IDH1<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">IDH2<\/jats:italic>\n                      ) mutations are common in intrahepatic cholangiocarcinoma (ICC), but their prognostic value is unclear. Using a large data set, we assessed their impact in resected and nonresected ICC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Adults from two medical centers (MSKCC and Erasmus) with ICC treated with curative-intent resection (resected) or managed nonoperatively (unresectable) who underwent next-generation sequencing were analyzed retrospectively. Kaplan-Meier and Cox regressions assessed the impact of IDH status on outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Of the 795 patients analyzed, 25% had\n                      <jats:italic toggle=\"yes\">IDH1\/2<\/jats:italic>\n                      mutations (\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      mut) and 43% underwent resection. Median overall survival (OS) of the cohort was 32 months in\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      mut and 28 months for\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      wt (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .2). High-risk genetic alterations (\n                      <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                      mut,\n                      <jats:italic toggle=\"yes\">KRAS<\/jats:italic>\n                      mut, and\n                      <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                      del) were more frequent in\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      wild-type (\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      wt; odds ratio, 2.26; q &lt; 0.001). OS was 19 months in patients with high-risk alterations versus 40 months in patients without (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). In resected patients, recurrence-free survival (RFS) in\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      mut was 20 months versus 14 months for\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      wt (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .018), and OS was 69 months versus 50 months, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .2). However, after controlling for high-risk alterations, the potential benefit of\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      mut was no longer apparent (RFS: hazard ratio [HR], 0.78;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .095; OS: HR, 0.88;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .4). In unresectable\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      mut patients, progression-free survival was 9.4 months versus 9.1 months for\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      wt (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .7), and OS was 22 months versus 18 months, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .13). There remained no differences after controlling for high-risk alterations.\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      status was not a significant survival predictor in multivariable models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      In this cohort of patients with ICC,\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      mut was not an independent predictor of survival, after controlling for high-risk alterations and clinical variables.\n                      <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                      mutational status alone should, therefore, not be used to guide prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/po-25-01261","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:59:13Z","timestamp":1785873553000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Prognostic Impact of IDH Mutations in Intrahepatic Cholangiocarcinoma"],"prefix":"10.1200","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0156-5236","authenticated-orcid":true,"given":"Rachel N.","family":"Harvey","sequence":"first","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7270-8249","authenticated-orcid":true,"given":"Rebecca","family":"Gelfer","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3315-4538","authenticated-orcid":true,"given":"Esther","family":"Drill","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Biostatistics Service, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Balachandran","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"D'Angelica","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Drebin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4595-8749","authenticated-orcid":true,"given":"T Peter","family":"Kingham","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Saadat","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0406-017X","authenticated-orcid":true,"given":"Kevin","family":"Soares","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2505-959X","authenticated-orcid":true,"given":"Alice C.","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1522-8054","authenticated-orcid":true,"given":"Ghassan K.","family":"Abou-Alfa","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, New York, NY"},{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"Trinity College Dublin School of Medicine, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5054-8192","authenticated-orcid":true,"given":"Andrea","family":"Cercek","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, New York, NY"},{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7029-4310","authenticated-orcid":true,"given":"James J.","family":"Harding","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, New York, NY"},{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8076-9199","authenticated-orcid":true,"given":"Eileen M.","family":"O'Reilly","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, New York, NY"},{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8611-840X","authenticated-orcid":true,"given":"Michail","family":"Doukas","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein Y.V.","family":"Homs","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1917-6973","authenticated-orcid":true,"given":"Bas","family":"Groot Koerkamp","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1635-5768","authenticated-orcid":true,"given":"William R.","family":"Jarnagin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.107064"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0446"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2015.07.005"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010104"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0310-z"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00727-4"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200015"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3375"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31829"},{"key":"e_1_3_7_11_2","article-title":"KRAS variants are associated with survival outcomes and genomic alterations in biliary tract cancers","author":"Gelfer R","unstructured":"Gelfer R, Gulla A, Kalvin HL, et al: KRAS variants are associated with survival outcomes and genomic alterations in biliary tract cancers. JCO Precis Oncol 10.1200\/PO.24.00263","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.5679"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32010044"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09132"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1137510"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06804-6"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.315"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3828-x"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2014.12.006"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3437"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2019.03.10"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.3836"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04603-7"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0210"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22543-z"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature16490"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.5153"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-25-01261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:59:23Z","timestamp":1785873563000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-25-01261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1200\/PO-25-01261"],"URL":"https:\/\/doi.org\/10.1200\/po-25-01261","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"2025-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2501261"}}